Dulayel Nasser Almufarrej

Ms. Dulayel Nasser Almufarrej


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 July 2026 in Applied Sciences
Verified
Journal Article
Open access
PDF file
DADulayel Nasser Almufarrej
Dulayel Nasser Almufarrej
Farouq Mohammad A. AlamFarouq Mohammad A. Alam
Farouq Mohammad A. Alam
Abdulkader Monier DaghistaniAbdulkader Monier Daghistani
Abdulkader Monier Daghistani
Modeling time-to-event data without accounting for risk factors may lead to biased conclusions. Therefore, researchers sometimes assume the existence of competing risks to accurately model life data. Furthermore, since medical research can be time-consuming and costly, experimenters may consider optimizing their use of resources by employing a censoring plan, such as a progressive Type-II censoring scheme. This study investigates statistical inference for a competing-risks model based on Stacy’s generalized gamma distribution under the latter censoring scheme. A couple of frequentist estimation methods—namely, maximum likelihood estimation and maximum product-of-spacings estimation—are used to obtain point estimates of the model parameters. Using the point estimators, asymptotic confidence intervals are constructed alongside two bootstrapping confidence intervals—namely, the percentile and Studentized bootstrap confidence intervals. Monte Carlo simulations are used to numerically examine the performance of both point and interval estimation using appropriate criteria. Overall, the simulations indicate that maximum product-of-spacings estimation outperforms maximum likelihood estimation, particularly in estimating the shape parameter under heavier censoring. The practical illustration of Stacy’s competing-risks model is achieved by analyzing two real medical datasets concerning pneumonia in intensive care and leukemia stem cell transplantation. Overall, the information criteria confirm that Stacy’s competing-risks model provides a robust fit relative to its submodels, offering a highly flexible framework for complex survival data.

28 November 2025 in Mathematics
Verified
Journal Article
Open access
PDF file
Farouq Mohammad A. AlamFarouq Mohammad A. Alam
Farouq Mohammad A. Alam
Abdulkader Monier DaghistaniAbdulkader Monier Daghistani
Abdulkader Monier Daghistani
DADulayel Nasser Almufarrej
Dulayel Nasser Almufarrej
Competing risks modeling plays a pivotal role in both reliability analysis for scientific and engineering fields and survival analysis within medical research. In real-world scenarios, failure or death (from a biological perspective) often arises from multiple risk factors that compete with one another. To adequately capture these complexities, it is essential to employ a flexible probabilistic framework, such as the competing risks model, which ensures suitability for intricate risk scenarios (e.g., analyzing data from aggressive diseases where treatment response and disease progression are closely interwoven). This study introduces Stacy’s competing risks model, built upon Stacy’s generalized gamma distribution, offering enhanced robustness and flexibility over existing models. The paper first develops the mathematical properties of the proposed model, followed by a detailed exploration of parameter estimation through various estimation methods. A key focus is accurately estimating shape parameters to gain deeper insights into the survival and failure mechanisms associated with the underlying phenomenon. The performance of different estimation approaches is assessed using Monte Carlo simulations, with results indicating that the least square, Cramér–von Mises, Anderson–Darling, right Anderson–Darling, and weighted least square had better performance and stable estimation accuracy compared with maximum likelihood maximum product of spacings methods. The model is applied to two real-world blood cancer datasets to demonstrate practical applicability, showing the superior performance and outstanding fit of the Anderson–Darling method among the other methods. The findings highlight the superior performance of Stacy’s competing risks model, supported by low Kolmogorov–Smirnov statistics and high p-values, affirming its suitability and robustness in modeling blood cancer data compared to other standard models.